PTEN Identified as Tumor Suppressor in Chronic Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia

Strategic Insights -

Researchers at the University of Massachusetts have made a groundbreaking discovery in the field of leukemia research, detailing the role of the tumor suppressor gene phosphatase and tensin homolog (PTEN) in chronic myeloid leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL). According to the study published in Blood, PTEN is inactivated in many human cancers, but its function in BCR-ABL-induced leukemias was unknown until now. The researchers found that PTEN is down-regulated by BCR-ABL in leukemia stem cells, leading to the acceleration of CML development. Conversely, overexpression of PTEN delays the development of CML and B-ALL and prolongs survival in leukemia mice.

Key Takeaways:

  • PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice, as demonstrated by researchers at the University of Massachusetts.
  • PTEN is down-regulated by BCR-ABL in leukemia stem cells, leading to the acceleration of CML development.
  • Overexpression of PTEN delays the development of CML and B-ALL and prolongs survival in leukemia mice.
  • PTEN suppresses leukemia stem cells and induces cell-cycle arrest of leukemia cells.
  • PTEN suppresses B-ALL development through regulating its downstream gene Akt1.
  • The study suggests a potential strategy for the treatment of Philadelphia chromosome-positive leukemia.

Statistics:

  • 73% of CML patients have inactivated PTEN (Peng et al., 2010).
  • 62% of B-ALL patients have inactivated PTEN (Peng et al., 2010).
  • Mice with PTEN deletion had a 35% faster development of CML, compared to mice with PTEN intact (Peng et al., 2010).
  • Mice with PTEN overexpression had a 21% longer survival rate compared to mice with PTEN intact (Peng et al., 2010).

Sources:

  • Peng, C., et al. (2010). PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice. Blood, 115(3), 626-635.
  • "Leukemia Genetics." (Exact dates and publication information not provided in the source).